Wheeler Bio looks to solve tech transfer challenges, raises $14m in seed funding 11-Jan-2022 By Jane Byrne Wheeler Bio, a newly established company aiming accelerate the translation of therapeutic innovation into clinical impact, recently closed a US$14m seed financing round.